Skip to main content
. 2022 Jul 7;4(3):100293. doi: 10.1016/j.ocarto.2022.100293

Table 5.

Assessment of dilution linearity recovery of the nine synovial fluid control samples (A-I). The analyses were done with or without predefined biomarker selection criteria at different dilution ranges. The data presented in this table was from one experiment (plate) where the samples were diluted and assessed as single sample up to quadruplicates.

Samples A-D Samples E-G Samples H,I
aSelection criteria Dilutions, range (span) 1–25x (25x) 2–25x (12.5x) 1–10x (10x) 2–10x (5x) 1–4x (4x)
Sample dilutions 1x, 2x, 4x, 10x, 25x 2x, 4x, 10x, 25x 1x, 2x, 4x, 10x 2x, 4x, 10x 1x, 2x, 4x
Samples, n 4 4 3 3 2
Biomarkers
Nb 19–36 32–41 42–48 42–51 44
CV % of NPX, mean (range) 11.8 (1.7–20.0) 10.5 (1.3–20.1) 10.9 (2.5–20.2) 10.9 (2.1–19.7) 14.0 (6.4–20.8)
Range of recovery, %
74.4–126.4
75.5–125.8
75.1–126.0
77.5–120.9
76.7–123.2


Samples A-D
Samples E-G
Samples H, I
No selection criteria Dilutions, range (span) 1–25x (25x) 2–25x (12.5x) 1–10x (10x) 2–10x (5x) 1–4x (4x)
Sample dilution, times 1x, 2x, 4x, 10x, 25x 2x, 4x, 10x, 25x 1x, 2x, 4x, 10x 2x, 4x, 10x 1x, 2x, 4x
Samples, n 4 4 3 3 2
Biomarkers
All, n 92 92 92 92 92
Values ​< ​LLOD, nc 17–27 17–27 22 22 19, 26
CV % of NPX, mean (range) 5.2 (1.7–145.5) 43.7 (1.7–145.5) 37.8 (2.5–117) 33.4 (2.5–117) 31.7 (6.4–82.2)
Range of recovery, % 8.6–358.2 14.2–298.7 10.9–272.6 26.5–216.5 26.4–188.7

NPX ​= ​normalized protein expression.

a

Selection criteria ​= ​values above lower limit of detection (LLOD), coefficient of variation (CV) of linearity <21% and recovery between 74 and 127%.

b

N ​= ​the range of number of biomarkers detected in sample groups at different dilutions. In Supplementary Table S7 the number of biomarkers detected in each sample (A-I) are presented.

c

Number of biomarker with values < LLOD in individual samples (A-I): 17 (A), 20 (B), 27 (C), 18 (D), 22 (E, F, G), 26 (H) and 19 (I).